Synapse News
MedStack secures $3.93 million CAD to capitalize on increased demand for healthtech
Healthcare security, privacy, and compliance startup MedStack has raised $3.93 million CAD ($3.1 million USD) to bolster its offering and support its expansion plans. The all-equity round was led by existing investors Blu Venture Investors (BVI) and Telus Ventures. It saw participation from existing investor Donville Kent Asset Management,…
Heads up, future startups: McMaster Seed Fund is now accepting applications
Launched today, the McMaster Seed Fund (MSF), is an early-stage investment vehicle designed to foster innovative startup companies coming out from McMaster research with the potential for significant economic and/or societal impact in the Hamilton region and beyond. Click here for more details on the application process and associated…
VoxNeuro receives Health Canada Class II Medical Device designation
VoxNeuro has received Health Canada Class II Medical Device designation for its proprietary Cognitive Health Assessment Management Platform™ (CHAMP). VoxNeuro will begin rolling out the software as a medical device across its Canadian Test Centers. This news comes hot on the heels of VoxNeuro’s FDA registration for the distribution of…
SOPHIE gives life science start-ups access to expertise and funds (Healthcare Technology)
A recent federal investment in a Hamilton-based, life science cluster has increased access to expertise and funds for innovative healthcare technology companies – like VoxNeuro. Synapse is a life science cluster that was launched by Hamilton’s regional innovation centre, the Innovation Factory. “Synapse was ready to make the…
Ontario Gov’t Invests $860k in Core Print Patterns to Manufacturer Components for COVID-19 Tests
Ontario Together Fund continues to support homegrown innovation and manufacturing to strengthen Ontario’s MedTech ecosystem The Ontario government is investing nearly $860,000 in Coreprint Patterns through the Ontario Together Fund. The investment will help the family-owned-and-operated business manufacture critical components for COVID-19…
Fusion Pharmaceuticals to Build 27,000 sqft Radiopharmaceutical Manufacturing Facility in Hamilton
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced it entered a 15-year lease agreement with Hamilton, Ontario-based McMaster University to build a 27,000 square foot current Good Manufacturing Practice (GMP) compliant…
Fusion Pharmaceuticals to Build Radiopharmaceutical Manufacturing Facility at McMaster Innovation Park
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced it entered a 15-year lease agreement with Hamilton, Ontario-based McMaster University to build a 27,000 square foot current Good Manufacturing Practice (GMP) compliant…
Celerite Labs files provisional patent in the United States
On June 1, 2021, Celerite Labs, The Forge client, filed another provisional patent application with the US Patent and Trademark Office. The patent application is directed to a novel method of performing cell migration assays. The Hamilton-based biotechnology startup, founded by Ishwar K. Puri, Dean of Engineering, and Rakesh Sahu, Research…
POV Hamilton Podcast – Featuring Synapse Director Alex Muggah
The POV Hamilton podcast is exploring innovation in #HamOnt. We’re talking to movers, shakers, entrepreneurs, researchers, and more about what is making the Steel City such a hot spot for technology, innovation, growth, and discovery. Informative and unique points-of-view are waiting, explore Hamilton, Ontario with us! Join us as we…